ABBVIE INC. DL-01/ US00287Y1091 /
| 3/18/2025 10:44:53 AM | Chg. - | Volume | Bid8:49:43 PM | Ask8:49:43 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 196.1600EUR | - | 9 Turnover: 1,765.4400 |
193.1800Bid Size: 280 | 193.7000Ask Size: 280 | 341.37 bill.EUR | - | - |
GlobeNewswire
3/20
Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pat...
GlobeNewswire
3/19
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets fo...
GlobeNewswire
3/11
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Fin...
GlobeNewswire
3/10
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Boa...
GlobeNewswire
3/5
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
GlobeNewswire
3/4
NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the C...
GlobeNewswire
2/27
CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
GlobeNewswire
2/26
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
2/21
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire
2/21
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire
2/14
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 20...
GlobeNewswire
2/13
Early Launch Metrics Indicate UCB’s Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthr...
GlobeNewswire
2/12
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Act...
